Looking at that trial report, there were 414 total patients and only 2 in 3 received the Activ-L. Spread that out across all of the PIs and you're left with a pretty small sample set.
I meant no disrespect to the PIs. My point was simply that there isn't much experience with the device and that just takes time. I personally hope the adoption rates for new devices take off because it would make my personal research and choices easier if there were thousands and tens of thousands of successful cases vs dozens and hundreds.
|